Krsnaa Diagnostics Limited (NSE:KRSNAA)
India
· Delayed Price · Currency is INR 675.45
+24.10 (3.70%)
Jun 6, 2025, 3:29 PM IST
Krsnaa Diagnostics Revenue
In the fiscal year ending March 31, 2025, Krsnaa Diagnostics had annual revenue of 7.17B INR with 15.74% growth. Krsnaa Diagnostics had revenue of 1.86B in the quarter ending March 31, 2025, with 11.90% growth.
Revenue
7.17B
Revenue Growth
+15.74%
P/S Ratio
3.04
Revenue / Employee
n/a
Employees
3,700
Market Cap
21.81B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 525.78B |
| Divi's Laboratories | 93.60B |
| Cipla | 271.45B |
| Apollo Hospitals Enterprise | 217.94B |
| Mankind Pharma | 122.07B |
| Zydus Lifesciences | 232.42B |
| Aurobindo Pharma | 317.24B |
| Alkem Laboratories | 129.65B |
Krsnaa Diagnostics News
- 6 weeks ago - Top stocks to buy today: Stock recommendations for April 23, 2025 - The Times of India
- 6 months ago - Lab stops blood collection at 400 BMC hosps over pending dues - The Times of India
- 7 months ago - Krsnaa Diagnostics shares surge nearly 6% as Q2 net sales reach ₹186.34 crore - Business Upturn
- 8 months ago - Stock in Focus: Krsnaa Diagnostics secures two major agreements in Ranchi - Business Upturn
- 9 months ago - Krsnaa Diagnostics to acquire 24% stake in start-up Apulki Healthcare - The Times of India
- 9 months ago - Krsnaa Diagnostics secures radiology services contract at Sadar Hospital, Ranchi - Business Upturn
- 9 months ago - Krsnaa Diagnostics acquires stake in India’s first PPP cancer and cardiac care hospitals - Business Upturn
- 9 months ago - Krsnaa Diagnostics share price surges over 3% after company agrees to acquire 23.53% stake in Apulki Healthcare - Business Upturn